IG 422 (Lisinopril 40 mg)
Pill with imprint IG 422 is Yellow, Round and has been identified as Lisinopril 40 mg. It is supplied by Cipla USA, Inc.
Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IG 422
Lisinopril
- Imprint
- IG 422
- Strength
- 40 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 76282-0422
- Inactive Ingredients
-
lactose monohydrate,
corn starch,
silicon dioxide,
magnesium stearate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "IG 422"
More about lisinopril
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (595)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: Angiotensin Converting Enzyme Inhibitors
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.